FUNDAMENTALS · Fundamentals · US Healthcare

Varex Imaging (VREX) Fundamentals 2026 — Revenue Analysis | SniperIQ

Varex Imaging (VREX) is a US-listed Healthcare company in Medical - Devices with a market capitalization of $450M, trading at

0.70 on the NASDAQ. This SniperIQ fundamentals page covers Varex Imaging's valuation, profitability (net margin -9.6%), revenue ($845M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$450M
Net Margin-9.6%
Revenue (FY25)$845M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Varex Imaging's market cap?

Varex Imaging (VREX) has a market capitalization of approximately $450M, trading at

0.70 on the NASDAQ. Market cap moves with the live share price.

What is Varex Imaging's P/E ratio?

Varex Imaging's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Varex Imaging?

Varex Imaging runs a net profit margin of -9.6%, a gross margin of 33.6%, and an operating margin of -3.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Varex Imaging generate?

Varex Imaging reported revenue of $845M for fiscal year 2025, with net income of -$70M and earnings per share (EPS) of -1.7. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Varex Imaging pay a dividend?

Varex Imaging does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Varex Imaging financially healthy?

Varex Imaging carries a debt-to-equity ratio of 0.80x and a current ratio of 3.20x, with a market beta of 0.90. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Varex Imaging a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Varex Imaging (VREX) the key facts are: market cap $450M, revenue $845M, 52-week range 6.76-14.565. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Varex Imaging's full fundamentals live

Get Varex Imaging's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: ClearPoint Neuro (CLPT) fundamentals · SOPHiA GENETICS (SOPH) fundamentals · Viemed Healthcare (VMD) fundamentals · Allogene Therapeutics (ALLO) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons